Sysmex Corporation (SSMXF)
OTCMKTS · Delayed Price · Currency is USD
13.30
0.00 (0.00%)
Aug 24, 2025, 8:00 PM EDT

Sysmex Company Description

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software.

It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others.

The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998.

Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Sysmex Corporation
Sysmex logo
CountryJapan
Founded1968
IndustryMedical Devices
SectorHealthcare
Employees10,533
CEOHisashi Ietsugu

Contact Details

Address:
1-5-1 Wakinohama-kaigandori
Kobe, 651-0073
Japan
Phone81 78 265 0500
Websitesysmex.co.jp

Stock Details

Ticker SymbolSSMXF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3351100007
SIC Code3826

Key Executives

NamePosition
Hisashi IetsuguChairman of the Board and Group Chief Executive Officer
Kaoru AsanoPresident and Representative Director
Iwane MatsuiSenior Executive Officer, Senior MD and Director
Kenji TachibanaSenior Executive Officer, Senior MD and Director
Tomokazu YoshidaSenior Executive Officer, MD, Chief Technology Officer and Director
Frank BuescherSenior Executive Officer
Kensuke IizukaSenior Executive Officer
Zuo Hui PengExecutive Officer
Takashi OnoMD, Senior Executive Officer and Director
Reiko WatanabeExecutive Officer and Executive Vice President of Medical Affairs Div.